TCMD
Tactile Systems Technology, Inc.
$23.64
+0.42%
2026-10-23
About Tactile Systems Technology, Inc.
Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema, phlebolymphedema, lipedema, venous insufficiencies, and other types of edema and leg ulcers; Entre Plus System, a pneumatic compression device for the at-home treatment of lymphedema, chronic edema, venous insufficiency, and chronic wounds. The company also provides Nimbl, a pneumatic compression platform for the treatment of upper extremity lymphedema; Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.
Key Fundamentals
P/E Ratio
21.24
Forward P/E
15.62
EPS (TTM)
$1.07
ROE
11.9%
Revenue Growth (YoY)
8.6%
Profit Margin
7.1%
Debt/Equity
6.42
Price/Book
2.31
Beta
0.79
Market Cap
$514.9M
Avg Volume (10D)
300K
Recent Breakout Signals
Recent Price Range (60 Days)
60D High
$30.42
60D Low
$21.29
Avg Volume
294K
Latest Close
$23.64
Get breakout alerts for TCMD
Sign up for Breakout Scanner to receive daily notifications when TCMD triggers breakout signals. Build custom AI screeners and backtest strategies.
Create your account7-day free trial, no card needed. Then $20/month.
Tactile Systems Technology, Inc. (TCMD) is listed on the NASDAQ (NASDAQ). Breakout Scanner monitors TCMD daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. TCMD operates in the Healthcare sector within the Medical Devices industry. Data is provided for informational purposes only and does not constitute financial advice.